A new metabolic mechanism describes how tumors disable “gatekeeper” cells to prevent immune response to cancer.

Microplastics turned up in every human bile sample tested and pushed duct cells toward mitochondrial dysfunction and senescence, with melatonin showing protective effects.

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

Directly transferring healthy mitochondria or cytoplasmic components into target cells is particularly relevant for regenerative medicine.

Eli Lilly has won FDA approval for its oral obesity drug Foundayo™ (orforglipron), but the stock bounce was short lived as investors pondered how much in sales it will generate this year as a price ...

Microgels mimic the mechanical properties of natural platelets to maximize the ability of the B peptides to create fibrin ...

These pillars are composed of polyacrylamide hydrogel, a material whose stiffness can be adjusted to match the ~5 kPa ...

Combination therapy led to complete remission in more than 50% of mice with different tumor types, many of which were resistant to ICB therapy alone.

The data shows when the protein is removed from neurons or has its signaling activity blocked with drugs, axonal fibers grew more effectively.

FDA approval of the first organoid-supported IND application augurs a future in which new approach methodologies supplant animal testing.

Once physical security measures are circumvented, there are no measures in place to protect cells from theft, abuse, or unauthorized use.